Michel de Wilde
Directeur/Bestuurslid bij VBI VACCINES INC.
Vermogen: 1 022 $ op 31-05-2024
Actieve functies van Michel de Wilde
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VBI VACCINES INC. | Directeur/Bestuurslid | 01-05-2016 | - |
Independent Dir/Board Member | 01-05-2016 | - | |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Directeur/Bestuurslid | 01-07-2014 | - |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Directeur/Bestuurslid | 01-07-2014 | - |
Loopbaan van Michel de Wilde
Eerdere bekende functies van Michel de Wilde
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Directeur/Bestuurslid | 01-12-2014 | 01-12-2019 |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 | 01-06-2013 |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | 01-06-2013 |
VBI VACCINES INC | Directeur/Bestuurslid | 25-07-2014 | - |
Independent Dir/Board Member | 25-07-2014 | - |
Opleiding van Michel de Wilde
Université Libre de Bruxelles | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
België | 2 |
Frankrijk | 2 |
Operationeel
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Independent Dir/Board Member | 2 |
Sectoraal
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Commercial Services |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Michel de Wilde
- Ervaring